Dajia Weikang: Legal Opinion of Shanghai Tongli Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Hunan Dajia Weikang Pharmaceutical Industry Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.